Blog Posts

Breaking News

Trump’s Full 2026 Budget Request Would Shift 340B Program from HRSA to CMS, Maintain Current OPA Funding

CMS would assume oversight of the 340B program under the White House’s full fiscal year 2026 budget proposal released May 30.
President Donald Trump’s fiscal year 2026 budget request released yesterday calls for moving control of the 340B program away from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Vermont Passes 340B Contract Pharmacy Access Bill with Controversial Hospital Price Caps, Sends to Governor

The Vermont legislature has passed a 340B bill with contract pharmacy, reporting and price cap provisions.
The Vermont legislature has passed a sweeping 340B bill with contract pharmacy protections, provider reporting requirements and controversial price caps [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Oklahoma Lawmakers Override Governor’s Veto, Enact 340B Contract Pharmacy Access Law

Oklahoma lawmakers resoundingly voted to override Gov. Kevin Stitt's (R) veto of a 340B contract pharmacy access bill.
In the final hours of Oklahoma’s legislative session late last night, lawmakers overwhelmingly voted to override Gov. Kevin Stitt’s (R) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

First 340B Administrative Dispute Resolution Panel Decision Sides with Drug Industry

The first decision was recently issued under HRSA's revised 340B Administrative Dispute Resolution process.
The first published decision under the revamped 340B Administrative Dispute Resolution (ADR) process sided with the drug industry, marking a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Stretching Scarce Federal Resources: How Conway Medical Center Is Redefining 340B’s Impact

SPONSORED CONTENT

The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in the pharmaceutical industry. In addition, there are questions regarding 340B’s scope including the contract pharmacy program and the definition of patient.

Read More »

Katie Miller, Key Player in Anti-340B ‘Dark Money’ Campaign, Leaves White House Adviser Role

Katie Miller, a key figure in a dark money anti-340B campaign, has left her role as a White House adviser.
A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Cassidy Says 340B ‘Was Never Meant to be Part of an Earnings Call’

U.S. Sen. Bill Cassidy (R-La.) discussed the 340B program in a recent interview with Punchbowl News.
A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Appeal Federal District Judge’s 340B Rebate Ruling in Favor of HHS

Two drugmakers are appealing a Washington, D.C. federal district judge's ruling against unilateral 340B rebate models.
Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BI Asks Tennessee Contract Pharmacies to Report Claims Data Ahead of New State Law, BMS Updates Contract Pharmacy Restrictions

Boehringer Ingelheim announced new 340B claims data requirements for Tennessee covered entities.
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Health Center Group Motion Denied in 5th Circuit; Drug Industry Makes Motion in Federal Court in South Dakota 

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana and South Dakota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live